Affiliation:
1. Department of Biotechnology, Bhupat and Jyoti Mehta School of BioSciences, Indian Institute of Technology Madras, Chennai 600 036, Tamilnadu, India
2. Department of Bioinformatics, Technische Universität München, Wissenschaftszentrum Weihenstephan, Freising, Germany
Abstract
Abstract:
Membrane proteins (MPs) play an essential role in a broad range of cellular functions,
serving as transporters, enzymes, receptors, and communicators, and about ~60% of membrane proteins
are primarily used as drug targets. These proteins adopt either -helical or -barrel structures
in the lipid bilayer of a cell/organelle membrane. Mutations in membrane proteins alter their structure
and function, and may lead to diseases. Data on disease-causing and neutral mutations in membrane
proteins are available in MutHTP and TMSNP databases, which provide additional features
based on sequence, structure, topology, and diseases. These databases have been effectively utilized
for analysing sequence and structure-based features in disease-causing and neutral mutations in
membrane proteins, exploring disease-causing mechanisms, elucidating the relationship between
sequence/structural parameters and diseases, and developing computational tools. Further, machine
learning-based tools have been developed for identifying disease-causing mutations using diverse
features, such as evolutionary information, physicochemical properties, atomic contacts, contact potentials,
and the contribution of different energetic terms. These membrane protein-specific tools are
helpful in characterizing the effect of new variants in the whole human membrane proteome. In this
review, we provide a discussion of the available databases for disease-causing mutations in membrane
proteins, followed by a statistical analysis of membrane protein mutations using sequence and
structural features. In addition, available prediction tools for identifying disease-causing and neutral
mutations in membrane proteins will be described with their performances. This comprehensive review
provides deep insights into designing mutation-specific strategies for different diseases.
Funder
Department of Science and Technology, Government of India
Russian Science Foundation
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,General Medicine
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献